Cognitive function with evolocumab in pediatric heterozygous familial hypercholesterolemia

MLA

Gaudet, D., et al. Cognitive Function with Evolocumab in Pediatric Heterozygous Familial Hypercholesterolemia. 2022. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1373000353&authtype=sso&custid=ns315887.

APA

Gaudet, D., Ruzza, A., Bridges, I., Maruff, P., Schembri, A., Hamer, A., Mach, F., Bergeron, J., Gaudet, I., St Pierre, J., Kastelein, J., Hovingh, G., Wiegman, A., Raal, F., Santos, R., & Hauser-Rct, I. (2022). Cognitive function with evolocumab in pediatric heterozygous familial hypercholesterolemia.

Chicago

Gaudet, D, A Ruzza, I Bridges, P Maruff, A Schembri, A Hamer, F Mach, et al. 2022. “Cognitive Function with Evolocumab in Pediatric Heterozygous Familial Hypercholesterolemia.” http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1373000353&authtype=sso&custid=ns315887.